# OnCo record nct06050122 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct06050122/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct06050122", "NCT06050122" ;
  schema:name "Efficacy and Safety of Patidegib Gel 2% for Preventing Basal Cell Carcinomas on the Face of Adults With Gorlin Syndrome"@en ;
  schema:description "A phase 3 trial of Patidegib Topical Gel in basal cell carcinoma, run by Sol-Gel Technologies, Ltd., now completed."@en ;
  schema:url <https://onco.cc/trials/nct06050122/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06050122> ;
  onco:status "completed" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "3" ;
  schema:startDate "2024-03-17" ;
  onco:cancers <https://onco.cc/cancers/basal-cell-carcinoma/> ;
  onco:drugs <https://onco.cc/drugs/patidegib/> ;
  onco:terms <https://onco.cc/terms/hedgehog-inhibitor-tolerability/> ;
  onco:trials <https://onco.cc/trials/patidegib-gel-gorlin-phase-2/>, <https://onco.cc/trials/stevie/> .